Meeting
2021 ASCO Annual Meeting
Genetic predictor of severe sorafenib-induced diarrhea and hand-foot syndrome (HFS).
Authors
Julia C. F. Quintanilha
University of North Carolina at Chapel Hill, Chapel Hill, NC
Julia C. F. Quintanilha , Susan Michelle Geyer , Jin Wang , Amy Etheridge , Stefanie Denning , Alessandro Racioppi , Kelli Hammond , Daniel Crona , Carol Elaine Pena , Sawyer B. Jacobson , Ghassan K. Abou-Alfa , Federico Innocenti
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Track
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Sub Track
Circulating Biomarkers
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 3030)
DOI
10.1200/JCO.2021.39.15_suppl.3030
Abstract #
3030
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2015 ASCO Annual Meeting
Genetics of ramucirumab-associated hypertension in the ROSE/TRIO-012 breast cancer trial.
First Author: John Robert Mackey
Poster
2012 ASCO Annual Meeting
Genetic polymorphisms influence in outcome of metastatic renal cell cancer patients treated with VEGF-targeted agents.
First Author: Fabio Augusto Barros Schutz
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Severe enterocolitis with capecitabine (CAPE) is not a predictor of gastrointestinal (GI) toxicity with infusional 5-fluorouracil (5-FU)–based regimens: An institutional analysis.
First Author: Marie Parish
Poster
2022 ASCO Genitourinary Cancers Symposium
HIF-pathway genes prognostic for progression-free and overall survival in metastatic clear cell renal cell carcinoma (mccRCC).
First Author: Patrick Tamukong